Bonviva 150mg

Bonviva 150 mg is a medication used in the treatment and prevention of osteoporosis, particularly in postmenopausal women. The active ingredient, Ibandronate sodium, belongs to a class of drugs known as bisphosphonates, which help to strengthen bones and reduce the risk of fractures by inhibiting bone resorption.

Bonviva is typically administered once a month, providing a convenient dosing schedule for patients. It works by binding to the bone tissue, slowing down the activity of cells that break down bone (osteoclasts), thus maintaining bone density and strength.

Patients taking Bonviva are usually advised to take it in the morning on an empty stomach with a full glass of water, remaining upright for at least 60 minutes afterward to minimize gastrointestinal side effects. As with any medication, patients need to discuss their medical history and any other medications they are taking with their healthcare provider before starting Bonviva to ensure its appropriateness and safety.